在正常的葡萄糖-6-酸脱酶活性患者中意外的拉斯布里卡斯诱导血液溶解
Saba Musleh Ud Din1, Khine Shan2, Tauseef Ur Rehman2
1Department of Internal Medicine, Memorial Healthcare System, Hollywood, FL, USA.
Journal of medical cases
|August 29, 2024
概括
拉斯布里卡斯可以引起血液溶解性贫血,即使在没有葡萄糖-6-酸盐脱酶 (G6PD) 缺乏症的患者中也是如此. 这一案例凸显了对这种罕见的不良影响在瘤溶解综合征管理中的谨慎和监测的必要性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 瘤溶解综合征 (TLS) 是一种瘤紧急情况,其特征是瘤细胞迅速分解.
- 在TLS中,高尿血症可能导致急性损伤,需要像拉斯布里卡斯这样的干预措施.
- 拉斯布里克酶是一种尿酸氧化酶,由于血液溶解风险,在患有葡萄糖-6-酸盐脱酶 (G6PD) 缺乏症的患者中禁用.
相关概念视频
Glucose Transporters
22.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.6K
Inborn Errors of Metabolism
146
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
146
Hypoglycemia and Glucagon
217
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
217
Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178
Glycolysis: Preparatory Phase
13.3K
In cellular metabolism (the complete breakdown of glucose to extract energy), glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...
13.3K


